Tryptanthrin attenuates TLR3-mediated STAT1 activation in THP-1 cells

Area of Science:

• Immunology
• Pharmacology
• Virology

Background:

• Dysregulated immune responses during viral infections can worsen disease severity.
• The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is crucial for innate immunity and macrophage activation.
• Tryptanthrin is a natural alkaloid with known antimicrobial and anti-inflammatory properties.

Purpose of the Study:

• To investigate the effects of tryptanthrin on toll-like receptor 3 (TLR3)-mediated STAT1 activation in macrophages.
• To determine if tryptanthrin can modulate the immune response triggered by viral infection mimics.

Main Methods:

• Utilized phorbol myristate acetate (PMA)-differentiated THP-1 cells as a macrophage model.
• Stimulated cells with polyinosinic-polycytidylic acid (poly IC), a TLR3 ligand, in the presence or absence of tryptanthrin.
• Analyzed levels of phosphorylated-STAT1 (p-STAT1), phosphorylated-IFN regulatory factor 3, and mRNA expression of interferon-stimulated genes.

Main Results:

• Tryptanthrin significantly decreased p-STAT1 levels in a dose-dependent manner following poly IC stimulation.
• Tryptanthrin did not impact p-STAT1 levels when cells were stimulated with lipopolysaccharide (LPS).
• Tryptanthrin suppressed poly IC-induced mRNA expression of STAT1-regulated interferon-stimulated genes and reduced IFN-β production.

Conclusions:

• Tryptanthrin effectively inhibits TLR3-mediated STAT1 activation and subsequent inflammatory gene expression in macrophages.
• Tryptanthrin demonstrates potential as a therapeutic agent for managing aberrant macrophage activation during viral infections.